Dr. Shevkoplyas is currently a Professor of Biomedical Engineering at the University of Houston. He received BS and MS degrees in Applied Mathematics & Physics from Moscow Institute of Physics & Technology (Russia) and a PhD in Biomedical Engineering from Boston University. After completing a postdoctoral fellowship in Chemistry and Chemical Biology at Harvard University, he served on the faculty of Tulane University as an Assistant and Associate Professor of Biomedical Engineering. His current research focuses on the development, clinical translation, and commercialization of microfluidic devices and systems for high-throughput cell separation in the fields of transfusion medicine and cellular therapy. He has authored 78 peer-reviewed articles (h-index of 44) and is an inventor on 11 issued U.S. patents. In 2012, Dr. Shevkoplyas was awarded an NIH Director's Transformative Research Award (R01). His research has been funded by the National Blood Foundation, the Bill & Melinda Gates Foundation, U.S. Department of Defense, Cancer Prevention and Research Institute of Texas, National Science Foundation, National Institutes of Health, and industrial partners.